Call toll-free 800.328.1267
The technology sector just had its worst quarter in 14 years. Every member declined in the period -- except for July's mystery stock. The SPDR Technology Sector ETF (XLK) fell 20 percent between March 31 and June 30 -- its worst quarterly performance since late 2008....
Advanced Micro Devices made new lows in June, but it remained the most actively traded symbol at TradeStation Securities for the fifth straight month. AMD declined as investors shunned economically sensitive semiconductor stocks. It's lost more than half its value...
The broader market has been super volatile lately, which makes the tranquil behavior of one retailer interesting: Dollar Tree. Notice how the discounter plunged on May 18 after Target's (TGT) poor quarterly results. Also notice how quickly it rebounded after its own...
American Airlines has been losing altitude for the last two months, and now an options trader is looking for new 52-week lows. Check out this transaction in the carrier yesterday afternoon: A block of 9,947 July 13.50 puts was purchased for $0.64.An equal number of...
Investors just pivoted back to growth stocks as inflation worries fade and a new quarter approaches. The S&P 500 jumped 6.4 percent in the holiday-shortened week between Friday, June 17, and Friday, June 20. More than 95 percent of the index's members advanced,...
2022 has been a difficult year for many investors as technology stocks retreat and inflation surges. Despite the volatility, there have been clear patterns based on company fundamentals and macroeconomic factors. Traders aware of certain cues could potentially benefit...
Traders usually buy options to position for a stock moving, but just the opposite happened in the No. 2 U.S. automaker yesterday. Check out this activity in Ford Motor (F): An investor sold 83,000 29-July 12 puts for $1.06.At the same time, he or she sold an equal...
United Therapeutics spent more than a year consolidating around its 2015 highs. Now the biotech may be attempting a breakout. Notice the surge to new all-time highs late last month. The rally followed news that the Food & Drug Administration approved its Tyvaso...
Biotechnology stocks have pulled back dramatically, but positive news has been growing as the sector tries to stabilize at a historic level. Positive news has emerged on several companies in the industry, including takeovers, regulatory approvals and drug-trial data....